Intravenous Administration

Infusion reaction rates to rituximab may be more significant among patients with systemic lupus erythematosus than other diseases, according to findings published in BMC Rheumatology.

ORLANDO — All infusion suite staff, including nurses and physicians, should participate in code drills to help them prepare for anaphylactoid reactions, heart attacks or any other adverse events that could arise while administering the treatment, according to Timothy R. Walker, RN.

Rockwell Medical Inc. announced the FDA has recently accepted the company’s new drug application for its IV formulation of Triferic with a Prescription Drug User Fee Act date set for March 28, 2020.